Fig. 2From: Impact of autoantibodies against the M2-muscarinic acetylcholine receptor on clinical outcomes in peripartum cardiomyopathy patients with standard treatmentFrequencies and titres of serum anti-M2-R. a Frequency. b Geometric titre. *p < 0.001 for the comparison of frequencies and geometric mean titres of anti-M2-R between the baseline, 1-year mark, and 2-year mark. #p < 0.05 between 1- and 2-year marksBack to article page